| COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 628 | 2020 |
| Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19 C Várnai, C Palles, R Arnold, HM Curley, K Purshouse, VWT Cheng, ... JAMA network open 5 (2), e220130-e220130, 2022 | 53 | 2022 |
| Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome RJ Lee, O Wysocki, T Bhogal, R Shotton, A Tivey, A Angelakas, T Aung, ... ESMO open 6 (1), 100005, 2021 | 18 | 2021 |
| Establishment of CORONET, COVID-19 risk in oncology evaluation tool, to identify patients with cancer at low versus high risk of severe complications of COVID-19 disease on … RJ Lee, O Wysocki, C Zhou, R Shotton, A Tivey, L Lever, J Woodcock, ... JCO clinical cancer informatics 6, e2100177, 2022 | 11 | 2022 |
| A multicentre retrospective analysis of toxicity in 6-weekly versus 3-weekly pembrolizumab M Rowe, L Eastlake, T Norris, T Farley, T Talbot Journal of Immunotherapy 44 (4), 175-178, 2021 | 8 | 2021 |
| Establishment of CORONET; COVID-19 Risk in Oncology Evaluation Tool to identify cancer patients at low versus high risk of severe complications of COVID-19 infection upon … RJ Lee, C Zhou, O Wysocki, R Shotton, A Tivey, L Lever, J Woodcock, ... MedRxiv, 2020.11. 30.20239095, 2020 | 6 | 2020 |
| Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients. AC Olsson-Brown, M Baxter, C Dobeson, L Feeney, R Lee, A Maynard, ... Journal of Clinical Oncology 39 (15_suppl), 12026-12026, 2021 | 4 | 2021 |
| An international comparison of presentation, outcomes and CORONET predictive score performance in patients with cancer presenting with COVID-19 across different pandemic waves O Wysocki, C Zhou, J Rogado, P Huddar, R Shotton, A Tivey, L Albiges, ... Cancers 14 (16), 3931, 2022 | 2 | 2022 |
| A novel program to address acute food insecurity among patients with cancer in Philadelphia. M Rowe, G Mancuso, WK Kelly, GD Garber, E Sina, A Leader Journal of Clinical Oncology 41 (16_suppl), e18739-e18739, 2023 | 1 | 2023 |
| The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort. AC Olsson-Brown, M Baxter, L Feeney, A Tivey, LJ Rodgers, S Mughal, ... Journal of Clinical Oncology 40 (16_suppl), 2522-2522, 2022 | 1 | 2022 |
| An analysis of survival in patients with castrate-resistant prostate cancer receiving enzalutamide with treatment breaks MP Rowe, S Walter, A Hidayat, A Pollard, T Norris, D Victor, J McGrane, ... Journal of Clinical Urology 15 (3), 257-263, 2022 | 1 | 2022 |
| The Impact of Treatment Crossover and Prostate-specific Antigen Flare with Enzalutamide and Abiraterone in Metastatic Castrate Resistant Prostate Cancer J McGrane, M Rowe, A Hidayat, S Walter, D Victor, T Norris, A Pollard Clinical Oncology 33 (1), e92, 2021 | 1 | 2021 |
| The use of intermittent enzalutamide dosing in the treatment of metastatic castrate-resistant prostate cancer. M Rowe, A Hidayat, S Walter, A Pollard, T Norris, D Victor, J McGrane, ... Journal of Clinical Oncology 38 (6_suppl), 81-81, 2020 | 1 | 2020 |
| NOTCH and BONUS as Vehicles for Early and Sustained Leadership Training T Fulton-Ward, E Khoury, M Rowe, MA Baxter, CM Jones Clinical Oncology 35 (4), e301-e302, 2023 | | 2023 |
| 241P Treatment and outcomes of patients with gastrointestinal toxicity following immunotherapy: A large multi-center retrospective study in the United Kingdom by the National … M Swaminathan, A Angelakas, M Baxter, J Cotton, CB Dobeson, ... Immuno-Oncology and Technology 16, 2022 | | 2022 |
| Observational study investigating Tolerance Of Anticancer Systemic Therapy In the Elderly (TOASTIE): a protocol H Dearden, MA Baxter, S Martin, M Rowe, K Zucker, CM Jones, ... BMJ open 11 (9), e051104, 2021 | | 2021 |
| Prostate-specific antigen (PSA) bounce following salvage radiotherapy to the prostate bed in a patient with prostate cancer post-prostatectomy M Rowe, E Adamson, J McGrane International Cancer Conference Journal 9 (4), 217-220, 2020 | | 2020 |
| 1690P Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19 R Lee, C Zhou, R Shotton, A Tivey, E Dickens, P Huddar, H McKenzie, ... Annals of Oncology 31, S999, 2020 | | 2020 |
| 1821P A multicentre analysis of toxicity in 6 weekly vs 3 weekly pembrolizumab dosing MP Rowe, L Eastlake, T Norris, T Farley, T Talbot Annals of Oncology 31, S1050-S1051, 2020 | | 2020 |
| Science Repository M Rowe, S Walter, A Hidayat, H Donkers, A Browne, T Norris, A Pollard, ... | | 2020 |
